• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压患者中纤维蛋白原和纤溶酶原激活物抑制剂(PAI-1)升高与心血管疾病的代谢危险因素相关。

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease.

作者信息

Landin K, Tengborn L, Smith U

机构信息

Department of Medicine II, Gothenburg University, Sahlgren's Hospital, Sweden.

出版信息

J Intern Med. 1990 Apr;227(4):273-8. doi: 10.1111/j.1365-2796.1990.tb00157.x.

DOI:10.1111/j.1365-2796.1990.tb00157.x
PMID:2182759
Abstract

The relationship between hypertension, glucose metabolism, fibrinogen and plasminogen activator inhibitor of endothelial cell type (PAI-1) was studied under conditions in which the influence of obesity and adipose tissue distribution (waist/hip ratio) were controlled. Twenty-two non-obese, middle-aged men with normal blood pressure (n = 11) and untreated mild hypertension (n = 11), respectively, participated in the study. Cholesterol, triglyceride and insulin levels were higher in hypertensive men than in the control group. Glucose disposal was studied as an indicator of insulin sensitivity using the euglycaemic clamp technique. The insulin effect tended to be less marked in men with hypertension. PAI-1 was higher in hypertensive men compared to the controls. A strong positive correlation was observed between PAI-1 and insulin levels as well as blood pressure. PAI-1 and fibrinogen levels correlated negatively with the rate of glucose disposal. Thus, even in these non-obese and mildly hypertensive individuals, an enhanced metabolic risk factor profile for cardiovascular disease was found. The metabolic aberrations were related to elevated fibrinogen and PAI-1 levels which, in turn, increase the risk of thrombus formation.

摘要

在控制肥胖及脂肪组织分布(腰臀比)影响的条件下,研究了高血压、糖代谢、纤维蛋白原与内皮细胞型纤溶酶原激活物抑制剂(PAI-1)之间的关系。22名非肥胖中年男性参与了该研究,其中11名血压正常,11名患有未经治疗的轻度高血压。高血压男性的胆固醇、甘油三酯和胰岛素水平高于对照组。使用正常血糖钳夹技术研究葡萄糖处置情况作为胰岛素敏感性指标。高血压男性的胰岛素作用往往不太明显。与对照组相比,高血压男性的PAI-1水平更高。观察到PAI-1与胰岛素水平以及血压之间存在强正相关。PAI-1和纤维蛋白原水平与葡萄糖处置率呈负相关。因此,即使在这些非肥胖和轻度高血压个体中,也发现心血管疾病的代谢危险因素谱有所增强。代谢异常与纤维蛋白原和PAI-1水平升高有关,进而增加血栓形成风险。

相似文献

1
Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease.高血压患者中纤维蛋白原和纤溶酶原激活物抑制剂(PAI-1)升高与心血管疾病的代谢危险因素相关。
J Intern Med. 1990 Apr;227(4):273-8. doi: 10.1111/j.1365-2796.1990.tb00157.x.
2
Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors.用二甲双胍治疗高血压中的胰岛素抵抗可降低血压和代谢危险因素。
J Intern Med. 1991 Feb;229(2):181-7. doi: 10.1111/j.1365-2796.1991.tb00328.x.
3
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.腹部肥胖与纤溶活性受损及纤溶酶原激活物抑制剂-1升高有关。
Metabolism. 1990 Oct;39(10):1044-8. doi: 10.1016/0026-0495(90)90164-8.
4
Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.在男性中,无论年龄、肥胖、体脂分布及相关代谢参数如何,雄激素活性较低都与促血栓形成因子的血浆水平较高相关。
Metabolism. 1997 Nov;46(11):1287-93. doi: 10.1016/s0026-0495(97)90232-8.
5
[The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].多沙唑嗪对血压、血脂、纤维蛋白原及纤溶酶原激活物抑制剂的影响。原发性高血压吸烟者与非吸烟者的比较研究
Tidsskr Nor Laegeforen. 1991 Apr 10;111(9):1102-5.
6
Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.心血管疾病高低风险男性的胰岛素敏感性与止血因素。风险因素干预研究组。
J Intern Med. 1999 Nov;246(5):489-95. doi: 10.1046/j.1365-2796.1999.00543.x.
7
Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.2型糖尿病患者后代纤溶酶原激活物抑制剂-1活性增加:与血浆胰岛素水平无关。
Diabetes Care. 2000 Jan;23(1):88-92. doi: 10.2337/diacare.23.1.88.
8
Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.高血压与代谢性心血管综合征:特别关注绝经前女性。
J Cardiovasc Pharmacol. 1992;20 Suppl 8:S15-21.
9
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.纤维蛋白原、凝血因子VII、组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂-1以及脂质作为慢性血液透析和持续性非卧床腹膜透析患者的心血管危险因素。
Am J Kidney Dis. 1996 Jun;27(6):848-54. doi: 10.1016/s0272-6386(96)90523-5.
10
Effects of short-term exercise training on plasminogen activator inhibitor (PAI-1).短期运动训练对纤溶酶原激活物抑制剂(PAI-1)的影响。
Med Sci Sports Exerc. 2003 Nov;35(11):1853-8. doi: 10.1249/01.MSS.0000093751.82616.F0.

引用本文的文献

1
Validation of a fibrinogen γ' enzyme-linked immunosorbent assay using a new monoclonal antibody: effects of bariatric surgery.使用新型单克隆抗体的纤维蛋白原γ'酶联免疫吸附测定法的验证:减肥手术的影响
Res Pract Thromb Haemost. 2024 Jan 17;8(1):102319. doi: 10.1016/j.rpth.2024.102319. eCollection 2024 Jan.
2
Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure.丁酸盐对高血压患者结肠中受损基因表达的影响。
Int J Mol Sci. 2023 Jan 31;24(3):2650. doi: 10.3390/ijms24032650.
3
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study.
在基于人群的KORA-Fit研究中收缩压、舒张压、脉压与止血参数之间的性别特异性关联:一项横断面研究
Thromb J. 2023 Jan 19;21(1):7. doi: 10.1186/s12959-023-00451-0.
4
Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects.纤维蛋白原、类纤维蛋白原1和类纤维蛋白原2蛋白及其作用。
Biomedicines. 2022 Jul 15;10(7):1712. doi: 10.3390/biomedicines10071712.
5
Hyperfibrinogenemia-mediated astrocyte activation.高纤维蛋白原血症介导的星形胶质细胞激活。
Brain Res. 2018 Nov 15;1699:158-165. doi: 10.1016/j.brainres.2018.08.023. Epub 2018 Aug 25.
6
Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus.2型糖尿病患者中的纤溶酶原激活物抑制剂-1与心包脂肪
Metab Syndr Relat Disord. 2017 Aug;15(6):269-275. doi: 10.1089/met.2017.0031. Epub 2017 May 15.
7
Effects of Epinephrine on Inflammation-Related Gene Expressions in Cultured Rat Cardiomyocytes.肾上腺素对培养的大鼠心肌细胞中炎症相关基因表达的影响。
Transl Perioper Pain Med. 2017;2(1):13-19.
8
Cerebrovascular disorders caused by hyperfibrinogenaemia.高纤维蛋白原血症所致的脑血管疾病。
J Physiol. 2016 Oct 15;594(20):5941-5957. doi: 10.1113/JP272558. Epub 2016 Jun 16.
9
Biocompatibility of cerium dioxide and silicon dioxide nanoparticles with endothelial cells.二氧化铈和二氧化硅纳米颗粒与内皮细胞的生物相容性。
Beilstein J Nanotechnol. 2014 Oct 17;5:1795-807. doi: 10.3762/bjnano.5.190. eCollection 2014.
10
Metabolic syndrome: is equine disease comparable to what we know in humans?代谢综合征:马的疾病与人的疾病有可比性吗?
Endocr Connect. 2014 Sep;3(3):R81-93. doi: 10.1530/EC-14-0038. Epub 2014 Jun 3.